This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: John Majda: Innovator in Monoclonal Antibody Methods
Introduction
John Majda is a notable inventor based in La Jolla, California. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibody methods. His innovative work has led to advancements in the ability to distinguish between antigenic aggregates, which is crucial for various medical applications.
Latest Patents
John Majda holds a patent for "Monoclonal antibody methods and compositions specific for single." This patent describes methods and compositions for producing monoclonal antibodies that can differentiate between antigenic aggregates based on a small number of antigenic determinants. The process involves immunizing a mammal to produce spleen cells, which are then fused with a stable cell line in vitro. The resulting hybrid cells are cultured to encourage the production of one colony per well, allowing for the screening of antibodies that can discriminate between different antigenic aggregates.
Career Highlights
Majda's career is marked by his dedication to research and innovation in the field of immunology. His work has not only contributed to scientific knowledge but has also paved the way for practical applications in medicine. He is affiliated with the University of California, where he continues to engage in groundbreaking research.
Collaborations
Throughout his career, John Majda has collaborated with esteemed colleagues such as Ivor Royston and Gayle Yamamoto. These collaborations have further enriched his research and contributed to the advancement of monoclonal antibody technologies.
Conclusion
John Majda's contributions to the field of immunology through his innovative patent on monoclonal antibody methods highlight his role as a significant inventor. His work continues to impact the scientific community and medical practices.